CXCL2/GRO beta/MIP-2/CINC-3 ELISA DY276-05 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemCXCL2/GRO beta/MIP-2/CINC-3 ELISA
CompanyR&D Systems, a Bio-Techne Brand
Price $450.00Supplier Page View Company Product Page
Catalog NumberDY276-05
NCBI Full Gene NameC-X-C motif chemokine ligand 2
NCBI Gene AliasesCINC-2a, GRO2, GROb, MGSA-b, MIP-2a, MIP2, MIP2A, SCYB2
StorageStore the unopened product at 2 - 8 °C. Do not use past expiration date
Detection TargetCXCL2/GRO beta/MIP-2/CINC-3
ReactivityHuman
Detection Range15.60 - 500 pg/mL
ApplicationsELISA
Quantity1 Kit (for 5 Plates)

Specifications/Features

Available conjugates: Sizes Available: 1 Kit (for 5 Plates)

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Single-cell RNA sequencing of baseline PBMCs predicts ICI efficacy and irAE severity in patients with NSCLCJ Immunother CancerMay 22, 2025Gyeong Dae Kim, So-I Shin, Pureum Sun, Jeong Eun Lee, Chaeuk Chung, Yea Eun Kang, Da Hyun Kang, Jihwan ParkPlasma CXCL2 levels were measured using a Human CXCL2/GRO beta DuoSet ELISA (R&D Systems, catalog no. DY276-05). Plasma levels of interferon-gamma (IFN-γ) were quantified using an ELISA kit (Cat# DY285B-05, R&D Systems

(2) Characteristics of Pulmonary Inflammation in Patients with Different Forms of Active TuberculosisInternational journal of molecular sciencesNovember 2, 2024Shepelkova GS, Evstifeev VV, Berezovskiy YS, Ergeshova AE, Tarasov RV, Bagirov MA, Yeremeev VV.

(3) Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell deathNature communicationsAugust 15, 2024Virard F, Giraud S, Bonnet M, Magadoux L, Martin L, Pham TH, Skafi N, Deneuve S, Frem R, Villoutreix BO, et al.

(4) Cell-Specific Regulation of Inflammatory Cytokines and Acute-Phase Proteins by the Glucocorticoid ReceptorMediators of InflammationNovember 28, 2023Rebecca Winkler, Hong Lu.Human CXCL1/GRO alpha DuoSet ELISA (catalog number DY275-05)Human CXCL2/GRO beta DuoSet ELISA (catalog number DY276-05)Human IL-8/CXCL8 DuoSet ELISA (catalog number DY208-05)Human CXCL10/IP-10 DuoSet ELISA (catalog number

(5) Gasdermin D-mediated keratinocyte pyroptosis as a key step in psoriasis pathogenesisCell death & diseaseSeptember 7, 2023Lian N, Chen Y, Chen S, Zhang Y, Chen H, Yang Y, Gu H, Chen Q, Li M, Chen X.(ELISA) ELISA was done according to the manufacturer’s instructions. ELISA kits of IL-1β (#DLB50), CXCL-2 (#DY276-05), CCL20 (#DM3A00), IL-8 (#D8000C), S100A8/A9 (#DS8900), TNF-α (#MTA00B), IL-17 (#M1700) were purchased

(6) c-Met Mediated Cytokine Network Promotes Brain Metastasis of Breast Cancer by Remodeling Neutrophil ActivitiesCancersMay 5, 2023Liu Y, Smith MR, Wang Y, D'Agostino R Jr, Ruiz J, Lycan T, Kucera GL, Miller LD, Li W, Chan MD, et al.subjected to ELISA assays for CXCL1, CXCL2, G-CSF, and GM-CSF (R&D system, Minneapolis, MN, USA #DY275, #DY276-05, #DY214, and #DY215, respectively). Neutrophils were cultured in a cancer cell-conditioned medium, or

(7) Serum interleukin-6, procalcitonin, and C-reactive protein at hospital admission can identify patients at low risk for severe COVID-19 progressionFrontiers in microbiologyJanuary 1, 2023Zobel CM, Wenzel W, Krüger JP, Baumgarten U, Wagelöhner T, Neumann N, Foroutan B, Müller R, Müller A, Rauschning D, et al.

(8) KDM6A Loss Recruits Tumor-Associated Neutrophils and Promotes Neutrophil Extracellular Trap Formation in Pancreatic CancerCancer researchNovember 15, 2022Yang J, Jin L, Kim HS, Tian F, Yi Z, Bedi K, Ljungman M, Pasca di Magliano M, Crawford H, Shi J.

(9) Cisplatin Promotes the Efficacy of Immune Checkpoint Inhibitor Therapy by Inducing Ferroptosis and Activating NeutrophilsFrontiers in pharmacologyJanuary 1, 2022Zhou Z, Zhao Y, Chen S, Cui G, Fu W, Li S, Lin X, Hu H.(RAB0116; Sigma-Aldrich, St. Louis, MO, United States), and human C-X-C motif chemokine ligand 2 (CXCL2) (DY276-05; R&D Systems, Minneapolis, MN, United States), according to the manufacturers’ protocols. 3 Results 3.1

(10) Multi-level inhibition of coronavirus replication by chemical ER stressNature communicationsSeptember 20, 2021Shaban MS, Müller C, Mayr-Buro C, Weiser H, Meier-Soelch J, Albert BV, Weber A, Linne U, Hain T, Babayev I, et al.

(11) Castration-mediated IL-8 promotes myeloid infiltration and prostate cancer progressionNature cancerAugust 1, 2021Lopez-Bujanda ZA, Haffner MC, Chaimowitz MG, Chowdhury N, Venturini NJ, Patel RA, Obradovic A, Hansen CS, Jacków J, Maynard JP, et al.Coomassie assay (Pierce, Cat#23200). IL-8 (BD Bioscience, Cat#555244), CXCL-2, and Cxcl15 (R&D Systems, Cat#DY27605 and Cat#DY442) were analyzed by ELISA kits following the manufacturer’s instructions. IL-8, CXCL-1,

(12) Azilsartan ameliorates ox-LDL-induced endothelial dysfunction via promoting the expression of KLF2Aging (Albany NY)May 15, 2021Wenfeng Li, Chenggao Wang, Dandan Zhang, Kanghua Zeng, Shihui Xiao, Feng Chen, Jun LuoCXCL1 in HUVECs were determined using the commercial ELISA assay kits (R&D System, MN, USA, #DCP00; #DY276-05). Briefly, the cell lysis sample was added to the wells of the 96-well plate and incubated with 1% BSA

(13) Patient Derived Colonoids as Drug Testing Platforms-Critical Importance of Oxygen ConcentrationFrontiers in pharmacologyJanuary 1, 2021Skovdahl HK, Gopalakrishnan S, Svendsen TD, Granlund AVB, Bakke I, Ginbot ZG, Thorsvik S, Flatberg A, Sporsheim B, Ostrop J, et al.release <100pg ml−1 were excluded from further assessment. ELISA kits for human CXCL1 (DY275-05), CXCL2 (DY276-05), CXCL5 (DY254-05), CXCL8 (DY208), CXCL10 (DY266-05), CXCL11 (DY672) and CCL20 (DY360), all from R&D Systems

(14) Macrophage development and activation involve coordinated intron retention in key inflammatory regulatorsNucleic acids researchJuly 9, 2020Green ID, Pinello N, Song R, Lee Q, Halstead JM, Kwok CT, Wong ACH, Nair SS, Clark SJ, Roediger B, et al.

(15) ADP secreted by dying melanoma cells mediates chemotaxis and chemokine secretion of macrophages via the purinergic receptor P2Y12Cell death & diseaseOctober 7, 2019Kloss L, Dollt C, Schledzewski K, Krewer A, Melchers S, Manta C, Sticht C, Torre C, Utikal J, Umansky V, et al.

(16) Fluid restriction reduces pulmonary edema in a model of acute lung injury in mechanically ventilated ratsPloS oneJanuary 1, 2019Ingelse SA, Juschten J, Maas MAW, Matute-Bello G, Juffermans NP, van Woensel JBM, Bem RA.

(17) Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5TheranosticsJanuary 1, 2019Giuliano S, Dufies M, Ndiaye PD, Viotti J, Borchiellini D, Parola J, Vial V, Cormerais Y, Ohanna M, Imbert V, et al.

(18) Transporters MRP1 and MRP2 Regulate Opposing Inflammatory Signals To Control Transepithelial Neutrophil Migration during Streptococcus pneumoniae Lung InfectionmSphereJuly 5, 2018Zukauskas A, Mrsny RJ, Cortés Barrantes P, Turner JR, Leong JM, McCormick BA.conducted as described above. Human ELISA kits were obtained from R&D Systems (DY210-05, DY217B-05, DY276-05, and DY20805), and assays were completed using the manufacturer’s instructions. To collect samples,

(19) Intracapillary immune complexes recruit and activate slan-expressing CD16+ monocytes in human lupus nephritisJCI insightJune 7, 2018Olaru F, Döbel T, Lonsdorf AS, Oehrl S, Maas M, Enk AH, Schmitz M, Gröne EF, Gröne HJ, Schäkel K.

(20) The Fli-1 transcription factor is a critical regulator for controlling the expression of chemokine C-X-C motif ligand 2 (CXCL2)Molecular immunologyJanuary 1, 2017Lou N, Lennard Richard ML, Yu J, Kindy M, Zhang XK.

Be the First to Write a Review!

CXCL2/GRO beta/MIP-2/CINC-3 ELISA

CXCL2/GRO beta/MIP-2/CINC-3 ELISA

CXCL2/GRO beta/MIP-2/CINC-3 ELISA from R&D Systems, a Bio-Techne Brand

Specifications/Features

R&D Systems, a Bio-Techne Brand

Citations (20)

Reviews

CXCL2/GRO beta/MIP-2/CINC-3 ELISA from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map